BE895842A - Nouveaux alcaloides ergopeptidiques, leur preparation et leur utilisation comme medicaments - Google Patents

Nouveaux alcaloides ergopeptidiques, leur preparation et leur utilisation comme medicaments

Info

Publication number
BE895842A
BE895842A BE1/10720A BE1010720A BE895842A BE 895842 A BE895842 A BE 895842A BE 1/10720 A BE1/10720 A BE 1/10720A BE 1010720 A BE1010720 A BE 1010720A BE 895842 A BE895842 A BE 895842A
Authority
BE
Belgium
Prior art keywords
medicaments
novel
preparation
ergopeptide
alkaloids
Prior art date
Application number
BE1/10720A
Other languages
English (en)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE895842A publication Critical patent/BE895842A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BE1/10720A 1982-02-12 1983-02-08 Nouveaux alcaloides ergopeptidiques, leur preparation et leur utilisation comme medicaments BE895842A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH89382 1982-02-12

Publications (1)

Publication Number Publication Date
BE895842A true BE895842A (fr) 1983-08-08

Family

ID=4197630

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/10720A BE895842A (fr) 1982-02-12 1983-02-08 Nouveaux alcaloides ergopeptidiques, leur preparation et leur utilisation comme medicaments

Country Status (6)

Country Link
JP (1) JPS58148888A (fr)
BE (1) BE895842A (fr)
FR (1) FR2528850B1 (fr)
HU (1) HU187003B (fr)
SU (1) SU1189351A3 (fr)
ZA (1) ZA83955B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999053324A1 (fr) * 1998-04-16 1999-10-21 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Verification de l'activite serotoninenergique par un test de la prolactine salivaire

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH505102A (de) * 1967-11-01 1971-03-31 Sandoz Ag Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
US3891652A (en) * 1973-06-28 1975-06-24 Squibb & Sons Inc Antianginal aryldecahydropyrrolo{8 3,4-f{9 quinolines
CH602765A5 (fr) * 1974-09-27 1978-07-31 Sandoz Ag

Also Published As

Publication number Publication date
ZA83955B (en) 1984-09-26
JPS58148888A (ja) 1983-09-05
FR2528850A1 (fr) 1983-12-23
JPH0352473B2 (fr) 1991-08-12
SU1189351A3 (ru) 1985-10-30
FR2528850B1 (fr) 1985-07-26
HU187003B (en) 1985-10-28

Similar Documents

Publication Publication Date Title
FR2531083B1 (fr) Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
FR2615191B1 (fr) Nouveaux benzo(b)pyrannes et pyrannopyridines, leur preparation et leur utilisation comme medicaments
FR2551064B1 (fr) Nouveaux esters et amides aromatiques, leur preparation et leur utilisation comme medicaments
FR2501199B1 (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
FR2535321B1 (fr) Nouveaux derives de l'ethanol, leur preparation et leur utilisation comme fongicides
BE894046A (fr) Alcaloides ergopeptidiques, leur preparation et leur utilisation comme medicaments
FR2590902B1 (fr) Nouveaux derives de la calcitonine, leur preparation et leur utilisation comme medicaments
PT76528B (fr) Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments
BE882601A (fr) Mercaptoacyldipeptides, leur preparation et leur utilisation
FR2531962B1 (fr) Nouveaux derives de la desoxyuridine, leur preparation et leur utilisation comme medicaments
OA07332A (fr) Oximes-éthers, leur préparation et leur utilisation.
FR2470134B1 (fr) Nouveaux antibiotiques, leur preparation et leur utilisation
FR2495168B1 (fr) Nouveaux alkylpolyoxyalkylene-carboxylates, leur preparation et leur utilisation comme agents tensio-actifs
BE896590A (fr) Nouveaux azepino-indoles leur preparation et leur utilisation comme medicaments
FR2560196B1 (fr) Nouvelles 8a-acylaminoergolines, leur preparation et leur utilisation comme medicaments
FR2527608B1 (fr) Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments
FR2540112B1 (fr) Nouveaux derives de la benzo(g)quinoleine, leur preparation et leur utilisation comme medicaments
BE883080A (fr) Nouvelles pyrazinobenzodiazepines, leur preparation et leur application comme medicaments
FR2532308B1 (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
FR2527206B1 (fr) Nouveaux derives de la 2(1h)-pyridinone, leur preparation et leur utilisation comme medicaments
FR2528431B1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
FR2536072B1 (fr) Nouveaux derives de la quinazoline, leur preparation et leur utilisation comme medicaments
FR2530634B1 (fr) Derives du carbapeneme, leur preparation et leur utilisation comme medicaments
FR2520741B1 (fr) Nouveaux derives du benzothiophene, leur preparation et leur utilisation comme medicaments
FR2522663B1 (fr) Nouveaux alcaloides ergopeptidiques, leur preparation et leur utilisation comme medicaments